Biogen Inc. financial data

Symbol
BIIB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
225 Binney Street, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
BIOGEN IDEC INC. (to 3/20/2015), BIOGEN IDEC INC (to 4/25/2007), IDEC PHARMACEUTICALS CORP / DE (to 11/12/2003), IDEC PHARMACEUTICALS CORP / CA (to 2/14/1997)
Latest financial report
Q1 2024 - Apr 24, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 219 % -14.7%
Quick Ratio 63 % +81.1%
Debt-to-equity 82.1 % -17.1%
Return On Equity 7.92 % -67.3%
Return On Assets 4.37 % -65.4%
Operating Margin 22.9 % -22.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 146M shares +0.59%
Common Stock, Shares, Outstanding 145M shares +0.63%
Entity Public Float 41.2B USD +40.1%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 145M shares +0.55%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +0.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 9.66B USD -4.37%
Costs and Expenses 8.34B USD +29.9%
Operating Income (Loss) 2.48B USD -33.1%
Nonoperating Income (Expense) -316M USD -392%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 465M USD +6.05%
Income Tax Expense (Benefit) 156M USD -72%
Net Income (Loss) Attributable to Parent 1.17B USD -62.7%
Earnings Per Share, Basic 8.04 USD/shares -62.8%
Earnings Per Share, Diluted 8 USD/shares -62.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 1.66B USD -2.4%
Inventory, Net 2.52B USD +96.5%
Other Assets, Current 1.17B USD -17.5%
Assets, Current 6.76B USD -30.8%
Deferred Income Tax Assets, Net 898M USD -25.9%
Property, Plant and Equipment, Net 3.28B USD -0.78%
Operating Lease, Right-of-Use Asset 428M USD +7.27%
Intangible Assets, Net (Excluding Goodwill) 8.28B USD +357%
Goodwill 6.23B USD +8.27%
Other Assets, Noncurrent 698M USD -49.5%
Assets 26.6B USD +8.01%
Accounts Payable, Current 387M USD -21.2%
Employee-related Liabilities, Current 164M USD -12.3%
Liabilities, Current 3.22B USD +6.9%
Accrued Income Taxes, Noncurrent 411M USD -25.6%
Deferred Income Tax Liabilities, Net 658M USD +162%
Operating Lease, Liability, Noncurrent 407M USD +24.3%
Other Liabilities, Noncurrent 777M USD -16.9%
Liabilities 11.4B USD +5.02%
Accumulated Other Comprehensive Income (Loss), Net of Tax -161M USD +6.69%
Retained Earnings (Accumulated Deficit) 18B USD +6.92%
Stockholders' Equity Attributable to Parent 14.8B USD +10.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 15.2B USD +10.3%
Liabilities and Equity 26.6B USD +8.01%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 553M USD +21.5%
Net Cash Provided by (Used in) Financing Activities -440M USD -913%
Net Cash Provided by (Used in) Investing Activities -66M USD +93.1%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 169M shares +0.48%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.07B USD -62.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 252M USD -3.92%
Deferred Tax Assets, Valuation Allowance 1.28B USD -36.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Operating Lease, Liability 490M USD +14%
Depreciation 261M USD +1.24%
Payments to Acquire Property, Plant, and Equipment 45.9M USD -31.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 1.18B USD -61.7%
Lessee, Operating Lease, Liability, to be Paid 592M USD +25.8%
Property, Plant and Equipment, Gross 5.71B USD +4.54%
Operating Lease, Liability, Current 90.3M USD -7.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 96.1M USD -10.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 106M USD -4.32%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +27%
Deferred Income Tax Expense (Benefit) 39.9M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 101M USD +153%
Lessee, Operating Lease, Liability, to be Paid, Year Three 83.5M USD +3.73%
Deferred Tax Assets, Operating Loss Carryforwards 1.7B USD -7.88%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -587M USD -78.9%
Current Income Tax Expense (Benefit) 441M USD -45%
Preferred Stock, Shares Authorized 8M shares 0%
Unrecognized Tax Benefits 173M USD -71.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 86.1M USD +31.1%
Operating Lease, Payments 116M USD +8.38%
Additional Paid in Capital 330M USD +261%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 15.1M USD -61.3%
Current Federal Tax Expense (Benefit) 378M USD -45.6%
Amortization of Intangible Assets 241M USD -2.31%
Depreciation, Depletion and Amortization 148M USD +31.3%
Deferred Tax Assets, Net of Valuation Allowance 2.93B USD +13.3%
Share-based Payment Arrangement, Expense -272M USD +0.15%
Deferred State and Local Income Tax Expense (Benefit) -12.7M USD -608%
Interest Expense 254M USD +4.36%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares